Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study to Assess Enzastaurin + R-CHOP in Subjects With DLBCL With the Genomic Biomarker DGM1™

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03263026
Recruitment Status : Recruiting
First Posted : August 28, 2017
Last Update Posted : April 19, 2019
Sponsor:
Information provided by (Responsible Party):
Denovo Biopharma LLC

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 2020
Estimated Study Completion Date : September 2021